Jose D Sandoval-Sus Francis Mogollon-Duffo Ankita Patel Nathan Visweshwar Damian A Laber Richard Kim Michael V Jagal
10.1186/s40425-017-0252-3
J Immunother Cancer
2017 Jun 20;5:49.
acute liver failure checkpoint inhibitors hodgkin lymphoma human immunodeficiency virus liver dysfunction
CC BY
https://pubmed.ncbi.nlm.nih.gov/28642818/
Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Hepatic Encephalopathy / drug therapy Hodgkin Disease / drug therapy Lymphoma, AIDS-Related / drug therapy
Antibodies, Monoclonal / therapeutic use Antineoplastic Agents / therapeutic use Hepatic Encephalopathy / drug therapy Hodgkin Disease / drug therapy Lymphoma, AIDS-Related / drug therapy Case Reports Adult Hepatic Encephalopathy / etiology Hodgkin Disease / complications Humans Lymphoma, AIDS-Related / complications Male Nivolumab Salvage Therapy / methods Antibodies, Monoclonal Antineoplastic Agents Nivolumab
PMC5477132
28642818
Nivolumab as salvage treatment in a patient with HIV-related relapsed/refractory Hodgkin lymphoma and liver failure with encephalopathy
2017